Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammation
Summary: Inflammatory bowel diseases (IBDs) are genetically complex and exhibit significant inter-patient heterogeneity in disease presentation and therapeutic response. Here, we show that mouse models of IBD exhibit variable responses to inhibition of MK2, a pro-inflammatory serine/threonine kinase...
Enregistré dans:
Auteurs principaux: | Lucia Suarez-Lopez, Bing Shui, Douglas K. Brubaker, Marza Hill, Alexander Bergendorf, Paul S. Changelian, Aisha Laguna, Alina Starchenko, Douglas A. Lauffenburger, Kevin M. Haigis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/76c5639d0d49434cae5abe91c97fbaf5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Transcriptome-Based Identification of a Functional <i>Fasciola hepatica</i> Carboxylesterase B
par: Yaretzi J. Pedroza-Gómez, et autres
Publié: (2021) -
TRIMER: Transcription Regulation Integrated with Metabolic Regulation
par: Puhua Niu, et autres
Publié: (2021) -
Development of a bioinformatics platform for analysis of quantitative transcriptomics and proteomics data: the OMnalysis
par: Punit Tyagi, et autres
Publié: (2021) -
Genomic and Transcriptomic Profiling of Brain Metastases
par: Christopher P. Wardell, et autres
Publié: (2021) -
A model of impaired Langerhans cell maturation associated with HPV induced epithelial hyperplasia
par: Zewen K. Tuong, et autres
Publié: (2021)